Addex Therapeutics Ltd Finance Costs
Addex Therapeutics Ltd (ADXN) reported Finance Costs of -CHF 5.83 thousand for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2025-09-30
- Addex Therapeutics Ltd finance costs for the quarter ending 2025-06-30 was -5.83K CHF, a 774.54% decline year-over-year.
- Addex Therapeutics Ltd finance costs for the quarter ending 2024-06-30 was 864.00 CHF, a 99.39% decline year-over-year.
- Addex Therapeutics Ltd finance costs for the quarter ending 2023-06-30 was 141.72K CHF, a 9.66% increase year-over-year.
- Addex Therapeutics Ltd finance costs for the quarter ending 2022-06-30 was 129.24K CHF, a 463.42% increase year-over-year.
| Period end | Finance Costs 3 month | Finance Costs 6 month | Finance Costs 12 month | Finance Costs 12 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | -5.83K CHF 6-K · filed 2025-09-30 | 13.32K CHF 6-K · filed 2025-09-30 | ||
| 2024-12-31 | 3.55K CHF 20-F · filed 2025-05-15 | |||
| 2024-06-30 | 864.00 CHF 6-K · filed 2025-09-30 | 1.48K CHF 6-K · filed 2025-09-30 | ||
| 2023-12-31 | 321.15K CHF 20-F · filed 2025-05-15 | 338.89K CHF 20-F · filed 2024-04-18 | ||
| 2023-06-30 | 141.72K CHF 6-K/A · filed 2023-12-21 | 173.22K CHF 6-K/A · filed 2023-12-21 | ||
| 2022-12-31 | 292.31K CHF 20-F · filed 2025-05-15 | 313.26K CHF 20-F · filed 2023-03-30 | ||
| 2022-06-30 | 129.24K CHF 6-K/A · filed 2023-12-21 | 190.49K CHF 6-K/A · filed 2023-12-21 | ||
| 2021-12-31 | 63.01K CHF 20-F · filed 2024-04-18 | |||
| 2021-06-30 | 22.94K CHF 6-K/A · filed 2022-09-14 | 43.68K CHF 6-K/A · filed 2022-09-14 | ||
| 2020-12-31 | 650.63K CHF 20-F · filed 2023-03-30 | |||
| 2019-12-31 | 213.32K CHF 20-F · filed 2022-03-10 | |||
| 2018-12-31 | 220.17K CHF 20-F · filed 2021-03-11 | |||
| 2017-12-31 | 45.35K CHF 20-F · filed 2020-04-27 |